James Antal, Director at CLEVELAND BIOLABS INC (CBLI), bought 1,881 shares at $3.18 ($6K) on 2011-09-16, disclosed to the SEC on 2011-09-20.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 1,846 | $6K | 98.1% |
| 2 | $3.22 | 35 | $113 | 1.9% |
| Total | $3.18 avg | 1,881 | $6K | 100% |
| Filing → |
| SIGA | SELL | 2019-06-07 | $171K | — | Filing → |
| CBLI | BUY | 2013-03-18 | $6K | — | Filing → |
| CBLI | BUY | 2012-09-25 | $6K | — | Filing → |